A critical review of modern and emerging absorbent dressings used to treat exuding wounds

International Wound Journal

Volumn 9, Issue 6, 2012, Pages 601-612

  Sweeney, India R ^a   Miraftab, Mohsen ^a   Collyer, Graham ^b  

^a UNIVERSITY OF BOLTON   (United Kingdom)

^b Sumed International (UK) Limited   (United Kingdom)

Author keywords

Absorbent dressings; Disadvantages; Exudate; Interactive; Smart

Indexed keywords

ABSORBENT; ALGINIC ACID; ANTIINFECTIVE AGENT; BECAPLERMIN; CADEXOMER IODINE; CALCIUM ALGINATE; CARBOXYMETHYLCELLULOSE; CHITOSAN; COMFEEL; DEXTRANOMER; DUODERM; EUSOL; GROWTH FACTOR; MATRIX METALLOPROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; CHRONIC WOUND; COST EFFECTIVENESS ANALYSIS; COTTON; FOAM; FOAM DRESSING; GAUZE DRESSING; GEL; HONEY; HUMAN; HYDROCOLLOID DRESSING; HYDROFIBER; NONHUMAN; POLYSACCHARIDE BEAD DRESSING; PRIORITY JOURNAL; PROTEINASE INHIBITION; SILVER DRESSING; SMART WOUND DRESSING; WOUND CARE; WOUND DRESSING; WOUND FLUID; WOUND HEALING;

ABSORBENT PADS; ALGINATES; ANTI-INFECTIVE AGENTS; BANDAGES; EQUIPMENT DESIGN; EXUDATES AND TRANSUDATES; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDE HYDROLASES; POLYSACCHARIDES; PROTEASE INHIBITORS; WOUNDS AND INJURIES;

EID: 84866040825     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00923.x     Document Type: Article

References (93)

1. Polak F, Clift M, Bower L, Sprange K. Buyers' guide: advanced wound dressings (CEP08038). London: NHS Purchasing and Supply Agency, 2008:90.
2. MeReC Bulletin. Evidence-based prescribing of advanced wound dressings for chronic wounds in primary care. MeReC Bull 2010;21.
3. Horken L, Stansfield G, Miller M. An analysis of systematic reviews undertaken on standard advanced wound dressings in the last 10 years. J Wound Care 2009;18:298-304.
4. Chaby G, Senet P, Vaneau M, Martel P, Guillaume JC, Meaume S, Teot L, Debure C, Dompmartin A, Bachelet H, Carsin H, Matz V, Richard JL, Rochet JM, Sales-Aussia N, Zagnoli A, Denis C, Guillot B, Chosidow O. Dressings for acute and chronic wounds. Arch Dermatol 2007;143:1297-304.
5. Winter GD. Formation of the scab and the rate of epithelisation of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-4.
6. Gamgee J. Absorbent and medicated surgical dressings. Lancet 1880;1:127.
7. Hinman CD, Maibach H. Effects of air exposure and occlusion on experimental human skin wounds. Nature 1963;200:377-8.
8. Field CK, Kerstein MD. Overview of wound healing in a moist environment. The American Journal of Surgery 1994;167 Suppl 1:2-6.
9. Thomas S. Wound exudate. In: Thomas S, editor. Surgical dressings and wound management. Cardiff, South Wales: Medetec, 2010:39-42.
10. White R. Managing exudate. Nurs Times 2001;97: 11-13.
11. Cutting KF. Wound exudate. In: White RJ, editor. Trends in wound care. Vol. 3. Dinton Salisbury: Quay Books, 2004.
12. Beldon P. Versiva® XC™ gelling foam dressing and the control of moderate to high exudate. Wounds UK 2008;4:74-7.
13. Woodall RD. Tissue viability. Living with leg ulcers: a patient's personal experience. Nurs Stand 1996;10:52.
14. Anderson I. Practical issues in the management of highly exuding wounds. Prof Nurse 2002;18:145-8.
15. Kujath P, Michelsen A. Wounds - from physiology to wound dressing. Dtsch Arztebl Int 2008;105:239-48.
16. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010;19:52-3.
17. Adderley U. Wound exudate: what it is and how to manage it. Wound Essent 2008;3:8-13.
18. Cameron J. Dermatological changes associated with venous leg ulcers. Wounds Essent 2007;2:60-6.
19. Dealey C. The physiology of wound healing. In: Dealey C, editor. The care of wounds: a guide for nurses. 2nd edn. Oxford: Blackwell, 1999:1-9.
20. Thomas S. Assessment and management of wound exudate. J Wound Care 1997;6:327-330.
21. Dowsett C. Moisture in wound healing: exudate management. Brit J Commun Nurs 2011;16:6-12.
22. Dealey C. Wound management products. In: Dealey C, editor. The care of wounds: a guide for nurses. 2nd edn. Oxford: Blackwell, 1999:68-95.
23. Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: the egg-box model. FEBS Lett 1973;32:195-8.
24. Stashak TS, Farstvedt E, Othic A. Update on wound dressings: indications and best use. Clin Tech Equine Pract 2004;3:148-63.
25. Blair SD, Jarvis P, Salmon M, McCollum C. Clinical trial of calcium alginate haemostatic swabs. Br J Surg 1990;77:568-70.
26. Timmons J. Alginates as haemostatic agents: worth revisiting? Wounds UK 2009;5:122-5.
27. Thomas A, Harding KG, Moore K. Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-α. Biomaterials 2000;21:1797-802.
28. Thomas S. Polysaccharide fibre dressings. In: Thomas S, editor. Surgical dressings and wound management. Cardiff, South Wales: Medetec, 2010:237-70.
29. Vermeulen HH, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg 2005;6:665-72.
30. Qin Y. Advanced wound dressings. J Text Inst 2001;92:127-38.
31. ®) in wound care. Ther Clin Risk Manag 2010;6:21-7.
32. Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, Amery CM, Edmonds ME, Gibby OM, Johnson AB, Jones GR, Masson E, Patmore JE, Price D, Rayman G, Harding KG. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess 2009;13.
33. Hampton S. Dressing for the occasion. Nurs Times 1999;95:58-60.
34. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Regen 1999;7:442-52.
35. Thomas S. Hydrocolloids: a guide to the composition, properties and uses of hydrocolloid dressings and the commercial presentations available. J Wound Care 1992;1:27-30.
36. Pudner R. Hydrocolloid dressings in wound management. J Commun Nurs 2001;15:44-8.
37. Foster AVM, Spencer S, Edmonds ME. Deterioration of diabetic foot lesions under hydrocolloid dressings. Pract Diabetes Int 1997;14:m62-4.
38. Mcintosh C. Are hydrocolloid dressings suitable for diabetic foot ulcers? Wound Essent 2007;2:170-2.
39. Seheiz M, Rauterberg A, Weib J. Allergic contact dermatitis from hydrocolloid dressings. Contact Dermat 1996;34:146.
40. Singh A, Halder S, Chumber S, Misra MC, Sharma LK, Srivastava A, Menon GR. Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg 2004;27:326-32.
41. Bouza C, Saz Z, Munoz A, Amate JM. Efficacy of advanced dressings in the treatment of pressure ulcers: a systematic review. J Wound Care 2005;14:193-9.
42. Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007;335:244-8.
43. Lawrence JC. The use of iodine as an antiseptic agent. J Wound Care 1998;7:421-5.
44. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83-100.
45. Bianchi J. Cadexomer-iodine in the treatment of venous leg ulcers: what is the evidence? J Wound Care 2001;10:225-9.
46. Archbold PG, Fitzpatrick JJ, Stewart BJ. Annual review of nursing research. Geriatric Nurs Res 2002;20:49.
47. Gottrup F, Apelqvist J. The challenge of using randomised trials in wound healing. Br J Surgery 2010;97:303-4.
48. Walker M, Lam S, Pritchard D. Biophysical properties of a Hydrofiber® cover dressing. Wounds UK 2010;6.
49. Brantigan CO. The history of understanding the role of growth factors in wound healing. Wounds 1996;8:78-90.
50. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Compl 2006;20:329-35.
51. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002;137:822-7.
52. Cullen B, Watt PW, Lundqvist C, Silcock D, Schmidt RJ, Bogan D, Light ND. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 2002;34:1544-56.
53. Wiegand C, Heinze T, Hipler UC. Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen 2009;17:511-21.
54. Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment. Diabetic Med 1999;16:889-909.
55. Waldrop J, Doughty D. Wound healing physiology. In: Bryant RA, editor. Acute & chronic wounds: nursing management. 2nd edn. Missouri: Mosby, 2000:17-39.
56. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ, Holtzin L, Schultz GS, Jurkiewicz MJ, Lynch JB. Enhancement of wound healing by topical treatment with epidermal growth factor. New Engl J Med 1989;321:76-9.
57. Ulubayram K, Cakar AN, Korkusuz P, Ertan C, Hasirci N. EGF containing gelatin-based wound dressings. Biomaterials 2001;22:1345-56.
58. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: a practical approach to the care of non-healing wounds and wound care dressings. J Am Acad Dermatol 2008;58:185-206.
59. Badylak SF. Extracellular matrix as scaffolds for tissue engineering in veterinary medicine: applications to soft tissue healing. Clin Tech Equine Pract 2004;3:173-81.
60. Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing - past, present and future perspectives. Surgeon 2008;6:172-7.
61. Baxter H. Surgical wounds and their care. Maxwell DH, editor. Surgical techniques in obstetrics and gynaecology. London: Churchill Livingstone, 2003:27-40.
62. Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P, Stevenson M. Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). Br J Surg 2009;96:1147-56.
63. Vermeulen H, van Hattem JM, Storm-Versloot MH, Ubbink DT, Westerbos SJ. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007;1:CD005486.
64. Pallai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: chemistry, solubility and fibre formation. Prog Polym Sci 2009;34:641-78.
65. Rouget C. Des substances amylacees dans le tissue des animaux, specialement les Atricules (Chitine). Comp Rend 1859;48:792-5.
66. Lee DS, Jeong SY, Kim YM, Lee MS, Ahn CB, Je JY. Anti-bacterial activity of amino derivatized chitosan against methicillin Resistant Staphylococcus Aureus (MRSA). Bioorg Med Chem 2009;17:7108-12.
67. Liu H, Du Y, Wang X, Sun L. Chitosan kills bacteria through cell membrane damage. Int J Food Microbiol 2004;95:147-55.
68. Vallapa N, Wiarachai O, Thongchul N, Pan J, Tangpasuthadol V, Kiatkamjornwong S, Hoven VP. Enhancing antibacterial activity of chitosan surface by heterogeneous quaternization. Carbohyd Polym 2011;83:868-75.
69. Kong M, Chen XG, Xing K, Park HJ. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int J Food Microbiol 2010;144:51-63.
70. Muzzarelli RAA. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohyd Polym 2009;76:167-82.
71. Park PJ, Je JY, Jung WK, Ahn CB, Kim SK. Anticoagulant activity of heterochitosans and their oligosaccharide sulphates. Eur Food Res Technol 2004;219:529-33.
72. Ohshima Y, Nishino K, Yonekura Y, Kishimoto S, Wakabayashi S. Clinical application of chitin non-woven fabric as wound dressing. Eur J Plast Surg 1987;10:66-9.
73. Okamoto Y, Kawakami K, Miyatake K, Morimoto M, Shigemasa Y, Minami S. Analgesic effects of chitin and chitosan. Carbohyd Polym 2002;49:249-52.
74. Jeon YJ, Kim SK. Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system. J Microbiol Biotechnol 2002;12:503-7.
75. Aranaz I, Megibar M, Harris R, Paños I, Miralles B, Acosta N, Galed G, Hera A. Functional characterization of chitin and chitosan. Curr Chem Biol 2009;3:203-30.
76. Knill CJ, Kennedy JF, Mistry J, Miraftab M, Smart G, Groocock MR, Williams HJ. Alginate fibres modified with unhydrolysed and hydrolysed chitosans for wound dressings. Carbohyd Polym 2004;55:65-76.
77. Tamura H, Tsuruta Y, Tokura S. Preparation of chitosan-coated alginate filament. Mater Sci Eng C 2002;20:143-7.
78. Fan L, Du Y, Zhang B, Yang J, Zhou J, Kennedy JF. Preparation and properties of alginate/carboxymethyl chitosan blend fibres. Carbohyd Polym 2006;65:447-52.
79. Kucharska M, Niekraszewicz A, Wiśniewska-Wrona M, Brzoza-Malczewska K. Dressing sponges made of chitosan and chitosan-alginate fibrids. Fibres Textiles East Eur 2008;16: 109-13.
80. Dai M, Zheng X, Xu X, Kong X, Li X, Guo G, Luo F, Zhao X, Wei YQ, Qian Z. Chitosan-alginate sponge: preparation and application in curcumin delivery for dermal wound healing in rat. J Biomed Biotechnol 2009;2009:595126.
81. Murakami K, Aoki H, Nakamura S, Nakamura SI, Takikawa M, Hanzawa M, Kishmoto S, Hattori H, Tanaka Y, Kiyosawa T, Sato Y, Ishihara M. Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials 2010;31:83-90.
82. Dong Y, Liu HZ, Xu L, Li G, Ma ZN, Han F, Yao HM, Sun YH, Li SM. A novel CHS/ALG bi-layer composite membrane with sustained antimicrobial efficacy used as wound dressing. Chin Chem Lett 2010;21:1011-14.
83. Cowan T. Wound care handbook. London: Mark Allen Healthcare, 2010-1.
84. Visavadia BG, Honeysett J, Danford MH. An effective treatment for chronic wound infections. Br J Oral and Maxillofac Surg 2008;46:55-6.
85. Molan PC. Re-introducing honey in the management of wounds and ulcers: theory and practice. Ostomy Wound Manage 2002;48:28-40.
86. Dunford C, Cooper MP. Using honey as a dressing for infected skin lesions. Nursing Times 2000;96(14 Suppl):7-9.
87. Lusby PE, Coombes A, Wilkinson JM. Honey: a potent agent for wound healing? J Wound Ostomy Cont Nurs 2002;29:295-300.
88. Okhiria O, Henriques A, Burton N, Peters A, Cooper RA. The potential of Manuka honey for the disruption of biofilms produced by strains of Pseudomonas aeruginosa isolated from wounds. Dublin, Ireland: September 6-9, Poster presentation at the 155th Meeting of the Society for General Microbiology, 2004.
89. Haynes JS. Properties of honey: its mode of action and clinical outcomes. Wounds UK 2011;7:50-7.
90. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 2002;66:86-92.
91. Philips PL, Wolcott RD, Fletcher J, Schultx GS. Biofilms made easy. Wounds Int 2010;1:1-6.
92. Zhou J, Tun TN, Hong SH, Mercer-Chalmers JD, Laabej M, Young AE, Jenkins AT. Development of a prototype wound dressing technology which can detect and report colonization by pathogenic bacteria. Biosens Bioelectron 2011;30:67-72.
93. Piletska EV, Stavroulakist G, Larcombet LD, Whitcombet MJ, Sharma A, Primroset S, Robinson GK, Piletskyt SA. Passive control of Quorum Sensing: Prevention of Pseudomonas aeruginosa Biofilm Formation by Imprinted Polymers. Biomacromolecules 2011;12:1067-71.